Taxus Cardium Pharmaceuticals Group (CRXM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2001 | 12-2000 | 09-2000 | 12-1999 | |
| Assets | ||||
| Current Assets | ||||
| Cash & Cash Equivalents | 69 | N/A | 489 | 489 |
| Marketable Securities | 24 | N/A | 554 | 554 |
| Receivables | 77 | 77 | 249 | 249 |
| Other current assets | 0 | 0 | 0 | 86 |
| TOTAL | $213 | $77 | $1,378 | $1,378 |
| Non-Current Assets | ||||
| PPE Net | 8 | N/A | 20 | 20 |
| Other Non-Current Assets | 2 | 0 | 9 | 0 |
| TOTAL | $10 | $N/A | $29 | $20 |
| Total Assets | $224 | $77 | $1,407 | $1,407 |
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 164 | 0 | 197 | 0 |
| Accrued Expenses | 22 | N/A | 25 | N/A |
| Other current liabilities | N/A | N/A | 49 | N/A |
| TOTAL | $186 | $N/A | $271 | $271 |
| Non-Current Liabilities | ||||
| TOTAL | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $186 | $N/A | $271 | $271 |
| Shareholders' Equity | ||||
| Common Shares | 35 | N/A | 35 | N/A |
| Retained earnings | -2,011 | N/A | -1,083 | -1,083 |
| Other shareholders' equity | 0 | 0 | 170 | 2,219 |
| TOTAL | $38 | $N/A | $1,136 | $1,136 |
| Total Liabilities And Equity | $224 | $0 | $1,407 | $1,407 |